U.S.-Egypt Cooperative Research: In Vitro and in Vivo Detection of Hepatitis C Virus Using Core Viral Antigens Specific Antibodies and Development of Novel Therapeutic Modalities

美国-埃及合作研究：使用核心病毒抗原特异性抗体体外和体内检测丙型肝炎病毒并开发新型治疗方式

• 批准号: 0403178
• 负责人: Said Goueli
• 金额: $ 2.4万
• 依托单位: Promega Corporation
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-02-01 至 2008-08-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=0403178&HistoricalAwards=false
• 关键词: U.S.; Egypt; Cooperative; Research; Vitro

0403178GoueliThis award is for support of a cooperative project by Dr. Said A. Goueli, Team leader of Technology Development at Promega Corporation, in Madison, Wisconsin, and Dr. Mostafa Kamel El Awady, Chairman, Dept. of Human Genetics, and Director of the Medical Biotechnology Program, at the National Research Center (NRC) in Cairo, Egypt. The two scientists plan to study the detection technologies of viral infection of Hepatitis C and the means for the development of a reliable and low cost test that will be affordable and suitable for developing countries. They also plan to study the development of a model system to monitor the course of viral infection and the efficacy of novel therapeutic modalities. This project will involve two laboratories with complementary capabilities to conduct research in an important field for both countries. The award will support a US-foreign collaboration in an area of mutual benefit. The project was generated as a result of a workshop on biotechnology organized by the National Institutes of Health (NIH) and the Egyptian Government, and will build on results that the two scientists had obtained in a previous collaborative project. NIH was involved in the evaluation of the project and in recommending its support. This project is being supported under the US-Egypt Joint Fund Program, administered by the US Department of State, which provides grants to scientists and engineers in both countries to carry out cooperative activities.

0403178 Gouelli该奖项是为了支持一个合作项目，由博士说A。位于威斯康星州麦迪逊的Promega公司技术开发团队负责人Goueli和部门主席Mostafa Kamel El Awady博士。他是埃及开罗国家研究中心（NRC）的人类遗传学博士和医学生物技术项目主任。 这两位科学家计划研究丙型肝炎病毒感染的检测技术，以及开发一种可靠、低成本、适用于发展中国家的检测方法。 他们还计划研究一种模型系统的开发，以监测病毒感染的过程和新型治疗方法的疗效。 该项目将涉及两个实验室，它们具有互补的能力，在两国的一个重要领域进行研究。 该奖项将支持美国与外国在互利领域的合作。 该项目是国家卫生研究所和埃及政府举办的生物技术讲习班的结果，将以这两位科学家在以前的一个合作项目中取得的成果为基础。 国家卫生研究所参与了对该项目的评估，并建议给予支持。 该项目得到美国-埃及联合基金方案的支持，该方案由美国国务院管理，向两国的科学家和工程师提供赠款，以开展合作活动。